Skip to main
IDXX

IDEXX Laboratories (IDXX) Stock Forecast & Price Target

IDEXX Laboratories (IDXX) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 44%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

IDEXX Laboratories is a globally diversified animal health company with a strong portfolio of diagnostic products, reference labs, and software services for the companion animal, livestock, and poultry industries. The company has a strong track record of delivering solid top and bottom line growth, driven by its innovative products and strong customer base. Additionally, with a growing pet ownership trend and increasing importance placed on pet health, the long-term outlook for IDXX remains positive.

Bears say

IDEXX Laboratories is a leading provider of diagnostic products and services for pets and livestock, with strong recurring revenue and customer retention. However, factors such as potential consolidation in the customer base, reliance on third parties for products and materials, and macroeconomic challenges in the animal health industry could impact their business. While they continue to invest in R&D and have strong partnerships, a return to typical growth rates in the animal health industry is crucial for their long-term success.

IDEXX Laboratories (IDXX) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 44% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IDEXX Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IDEXX Laboratories (IDXX) Forecast

Analysts have given IDEXX Laboratories (IDXX) a Buy based on their latest research and market trends.

According to 9 analysts, IDEXX Laboratories (IDXX) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $721.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $721.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IDEXX Laboratories (IDXX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.